ECSS
IDXX icon

Eurizon Capital SGR SpA’s Idexx Laboratories IDXX Stock Holding History

Eurizon Capital SGR SpA’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Buy
27,291
+4,018
+17% +$2.25M 0.04% 288
2026
Q1 		$13.1M Sell
23,273
-1,106
-5% -$709K 0.04% 291
2025
Q4 		$16.5M Buy
+24,379
New +$16.6M 0.05% 228

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Eurizon Capital SGR SpA's IDXX Position: Q2 2026 in Review

Eurizon Capital SGR SpA increased its Idexx Laboratories (IDXX) stake by 17% in Q2 2026, buying an estimated $2.25M and bringing the position to 27,291 shares worth $14.4M. The position accounts for 0.04% of the portfolio, ranked #288.

Eurizon Capital SGR SpA first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $16.5M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Eurizon Capital SGR SpA held 27,291 shares of Idexx Laboratories worth $14.4M as of Q2 2026.
  • Eurizon Capital SGR SpA bought 4,018 Idexx Laboratories shares in Q2 2026, an estimated $2.25M.
  • Idexx Laboratories made up 0.04% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #288 holding.
  • Eurizon Capital SGR SpA first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's Idexx Laboratories position peaked at $16.5M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.